Stay updated on MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial page.

Latest updates to the MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows a new site revision notice (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure and an older Revision: v3.3.2 in the footer. These changes do not affect the study information or its accessibility; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedAdded related topics: Ovarian cancer and MedlinePlus Genetics to the study page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0, indicating a minor update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page removed an ancillary funding notice and related topics links (Ovarian cancer and MedlinePlus Genetics). Core trial information remains unchanged.SummaryDifference0.5%

- Check62 days agoChange DetectedNo significant changes detected between the screenshots. The page remains the Study Details page for MITO27 (NCT03539328) with the same sections and content.SummaryDifference0.4%

- Check77 days agoChange DetectedRemoved the MedlinePlus Genetics topic on ovarian cancer, narrowing the page's coverage of that specific topic.SummaryDifference0.2%

Stay in the know with updates to MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial page.